Rep. Rudy Yakym Named 2024 Legislator of the Year
January 14, 2025 — Indianapolis –The Indiana Life Sciences Association is pleased to announce Rep. Rudy Yakym III as the organization’s 2024 Legislator of the Year. Rep. Yakym (IN-2) has been a valued partner in legislation providing patients with access to therapies and supporting innovation in the life sciences. He is a fourth-generation Hoosier, born […]
SBIR/STTR Reauthorization Sign-On Letter
This letter is now closed. Thank you to all who signed-on. To view the final letter, please click here. If you would like to share your SBIR/STTR experience with your Congressional representatives, please consider using AdvaMed’s Mobilization Tool. The Issue The authorizing legislation for the SBIR/STTR programs is set to expire on September 30, 2022. This program […]
Legislators of the Year
Each year, the Indiana Life Sciences Association recognizes a state or federal elected official as our, “Legislator of the Year”. The award is given in recognition of a legislator’s commitment to excellence in public health policy and service to Indiana’s health science business community. A list of past recipients follows. 2024 Rep. Rudy Yakym III […]
IHIF Announces Rep. Jackie Walorski as 2019 Legislator of the Year
October 1, 2019 – INDIANAPOLIS – The Indiana Health Industry Forum is pleased to announce Representative Jackie Walorski (IN-2) as the group’s 2019 Legislator of the Year. Rep. Walorski has been a strong and vocal leader in the effort to repeal the Medical Device Tax and her backing for this issue has generated tremendous bipartisan […]
Policy Forum
Indiana Life Sciences Association’s Policy Forum will work with the Indiana Life Sciences Association board and leadership to address state and federal policy issues that affect the life sciences business community and Hoosier patients’ access to therapies. Our objectives are to increase awareness of current, industry-related public policy activities and issues and facilitate opportunities for […]
Most Favored Nation Endangers Innovation
Importing International Reference Pricing in the U.S. Jeopardizes Our Fight Against COVID-19 and Patient Access to Innovative Medicines By Kristin Jones, President and CEO, Indiana Health Industry Forum In late July, President Trump issued a series of executive orders affecting the access to and affordability of innovative medicines. One of the orders focuses specifically on […]